About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 972705, 9 pages
http://dx.doi.org/10.1155/2013/972705
Clinical Study

Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation

1Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan
2Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
3Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto 606-8507, Japan
4Department of Diagnostic Pathology, Kyoto University, Kyoto 606-8507, Japan
5Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan

Received 30 December 2012; Revised 19 March 2013; Accepted 24 April 2013

Academic Editor: Stanislav Vukmanovic

Copyright © 2013 Atsushi Yoshizawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Sugawara, S. Tamura, J. Kaneko, J. Togashi, M. Makuuchi, and N. Kokudo, “Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation,” Digestive Surgery, vol. 26, no. 6, pp. 482–486, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Ashihara, H. Tsuji, H. Sakashita et al., “Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival,” Transplantation, vol. 83, no. 4, pp. 506–509, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Hori, S. Uemoto, Y. Takada et al., “Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?” Surgery, vol. 147, no. 6, pp. 840–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Vaidya, D. Partlow, B. Susskind, M. Noor, T. Barnes, and K. Gugliuzza, “Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay,” Transplantation, vol. 82, no. 11, pp. 1524–1528, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. I. Musat, R. M. Agni, P. Y. Wai et al., “The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation,” The American Journal of Transplantation, vol. 11, no. 3, pp. 500–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Egawa, S. Uemoto, Y. Takada et al., “Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver transplantation in humans,” Liver Transplantation, vol. 13, no. 9, pp. 1262–1271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Demetris, O. Adeyi, C. O. Bellamy, et al., “Liver biopsy interpretation for causes of late liver allograft dysfunction,” Hepatology, vol. 44, no. 2, pp. 489–501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Haga, H. Egawa, Y. Fujimoto et al., “Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation,” Liver Transplantation, vol. 12, no. 3, pp. 457–464, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Sakashita, H. Haga, E. Ashihara et al., “Significance of C4d staining in ABO-identical/compatible liver transplantation,” Modern Pathology, vol. 20, no. 6, pp. 676–684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. D. Wallace, E. F. Reed, D. Ross, C. R. Lassman, and M. C. Fishbein, “C4d staining of pulmonary allograft biopsies: an immunoperoxidase study,” Journal of Heart and Lung Transplantation, vol. 24, no. 10, pp. 1565–1570, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. L. E. Creary, J. Girdlestone, J. Zamora, J. Brown, and C. V. Navarrete, “Molecular typing of HLA genes using whole genome amplified DNA,” Transfusion, vol. 49, no. 1, pp. 57–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Takaya, O. Bronsther, Y. Iwaki et al., “The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors,” Transplantation, vol. 53, no. 2, pp. 400–406, 1992. View at Scopus
  13. M. Castillo-Rama, M. J. Castro, I. Bernardo et al., “Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility,” Liver Transplantation, vol. 14, no. 4, pp. 554–562, 2008. View at Publisher · View at Google Scholar · View at Scopus